Abstract
Objectives
To evaluate cancer treatment–related toxicities in young head and neck cancer (HNC) patients.
Material and methods
A total of 44 patients were included in the present retrospective cohort study, which was designed to access oral toxicities of cancer treatment in young (< 45 years of age, Group I, n = 22) and old (> 58 years of age, Group II, n = 22) HNC patients with similar tumor stage and treatment protocols. Oral mucositis (OM), xerostomia, dysphagia, dysgeusia, trismus, and radiodermatitis were assessed during days 7th, 21st, and 35th of head and neck radiotherapy (HNRT) according to previously validated scales (World Health Organization criteria and the National Cancer Institute and Common Terminology Criteria for Adverse Events version 4.0).
Results
Patients from both groups showed high incidence and severity of oral toxicities by the end of the HNRT with OM (81.9% (Group I); 63.6% (Group II)) and xerostomia (72.6% (Group I); 77.2% (Group II)) being the most prevalent toxicities. No differences regarding xerostomia, dysphagia, dysgeusia, and radiodermatitis incidences or severity could be observed between groups. However, higher incidences and severity of OM at 21st and 35th fractions (odds ratio = 2.22 and 5.71, respectively) and trismus at 21st and 35th fractions (odds ratio = 6.17 and 14.5, respectively) were observed throughout the treatment in young patients when compared to older patients (p < 0.01 and p < 0.05, respectively).
Conclusion
Young HNC patients are more affected by cancer treatment–related OM and trismus despite the similarities in clinical staging and treatment protocols with elderly patients.
Similar content being viewed by others
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:1–31. https://doi.org/10.3322/caac.21492
Marta GN, Jr WN, Feher O, Carvalho AL, Kowalski LP (2015) Induction chemotherapy for oral cavity cancer patients: current status and future perspective. Oral Oncol 51(12):1069–1075. https://doi.org/10.1016/j.oraloncology.2015.10.009
Sloan P, Gale N, Hunter K, Lingen MW, Nylander K, Reibel J et al (2017) Malignant surface epithelial tumours. In: El-Naggar AK, Chan JK, Grandis Jennifer R, Takata T, Slootweg PJ (eds) organizadores, 4th edn. WHO Classif Head Neck Tumours, pp 109–111
Pelucchi C, Gallus S, Garavello W, Bosetti C, La Vecchia C (2008) Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver. Eur J Cancer Prev 17(4):340–344. https://doi.org/10.1097/CEJ.0b013e3282f75e91
Hashibe M, Brennan P, Chuang SC (2009) Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomark Prev 18(2):541–550. https://doi.org/10.1158/1055-9965.EPI-08-0347
de Castro JG, dos Santos-Silva AR, Aparecida de Azevedo Koike Folgueira M, Toporcov T (2016) Tongue cancer in the young. Curr Opin Oncol 28(3):193–194. https://doi.org/10.1097/CCO.0000000000000285
Llwellyn CD, Johnson NW, Warnakulasuriya KA (2001) Risk factors for squamous cell carcinoma of the oral cavity in young people- a comprehensive literature review. Oral Oncol 37(5):401–418. https://doi.org/10.1016/S1368-8375(00)00135-4
Ribeiro AC, Silva AR, Simonato LE, Salzedas LM, Sundefeld ML, Soubhia AM (2009) Clinical and histopathological analysis of oral squamous cell carcinoma in young people: a descriptive study in Brazilians. Br J Oral Maxillofac Surg 47(2):95–98. https://doi.org/10.1016/j.bjoms.2008.05.004
Tsukuda M, Ooishi K, Mochimatsu I, Sato H (1993) Head and neck carcinomas in patients under the age of forty years. Jpn J Cancer Res 84(7):748–752. https://doi.org/10.1111/j.1349-7006.1993.tb02039.x
Toporcov TN, Znaor A, Zhang ZF, Yu GP, Winn DM, Wei Q, Vilensky M, Vaughan T, Thomson P, Talamini R, Szeszenia-Dabrowska N, Sturgis EM, Smith E, Shangina O, Schwartz SM, Schantz S, Rudnai P, Richiardi L, Ramroth H, Purdue MP, Olshan AF, Eluf-Neto J, Muscat J, Moyses RA, Morgenstern H, Menezes A, McClean M, Matsuo K, Mates D, Macfarlane TV, Lissowska J, Levi F, Lazarus P, la Vecchia C, Lagiou P, Koifman S, Kjaerheim K, Kelsey K, Holcatova I, Herrero R, Healy C, Hayes RB, Franceschi S, Fernandez L, Fabianova E, Daudt AW, Curioni OA, Maso LD, Curado MP, Conway DI, Chen C, Castellsague X, Canova C, Cadoni G, Brennan P, Boccia S, Antunes JL, Ahrens W, Agudo A, Boffetta P, Hashibe M, Lee YC, Filho VW (2015) Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium. Int J Epidemiol 44:169–185. https://doi.org/10.1093/ije/dyu255
Vissink A, Jansma J, Spijkervet FKL, Burlage FR, Coppes RP (2003) Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 14(3):199–212. https://doi.org/10.1177/154411130301400305
Merlano MC, Monteverde M, Colantonio I, Denaro N, Lo Nigro C, Natoli G, Giurlanda F, Numico G, Russi E (2012) Impact of age on acute toxicity induced by bio- or chemo-radiotherapy in patients with head and neck cancer. Oral Oncol 48(10):1051–1057. https://doi.org/10.1016/j.oraloncology.2012.05.001
Friedlander PL, Schantz SP, Shaha AR et al (1998) Squamous cell carcinoma of the tongue in young patients: a matched-pair analysis. Head Neck 20:363–368. https://doi.org/10.1002/(SICI)1097-0347(199808)20:5<363::AID-HED1>3.0.CO;2-W
Eisbruch A, Rhodus N, Rosenthal D, Murphy B, Rasch C, Sonis S, Scarantino C, Brizel D (2003) How should we measure and report radiotherapy-induced xerostomia? Semin Radiat Oncol 13(3):226–234. https://doi.org/10.1016/S1053-4296(03)00033-X
Brandão TB, Morais-Faria K, Ribeiro ACP, Rivera C, Salvajoli JV, Lopes MA, Epstein JB, Arany PR, de Castro G Jr, Migliorati CA, Santos-Silva AR (2018) Locally advanced oral squamous cell carcinoma patients treated with photobiomodulation for prevention of oral mucositis: retrospective outcomes and safety analyses. Support Care Cancer 26(7):2417–2423. https://doi.org/10.1007/s00520-018-4046-z
Goldstein DP, Irish JC (2005) Head and neck squamous cell carcinoma in the young patient. Curr Opin Otolaryngol Head Neck Surg 13:207–211. https://doi.org/10.1097/01.moo.0000170529.04759.4c
Sonis TS, Hashemi S, Epstein JB, Nair RG, Raber-Durlacher JE (2016) Could the biological robustness of low level laser therapy (photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients. Oral Oncol 2016(54):7–14. https://doi.org/10.1016/j.oraloncology.2016.01.005
Ferreira KASL, Kimura M, Teixeira MJ (2006) The WHO analgesic ladder for cancer pain control, twenty years of use. How much pain relief does one get from using it? Support Care Cancer 14:1086–1093. https://doi.org/10.1007/s00520-006-0086-x
Shillingburg A, Kanate AS, Hamadani M, Wen S, Craig M, Cumpston A (2017) Treatment severe mucositis pain with oral ketamine mouthwash. Support Care Cancer 25(7):2215–2219. https://doi.org/10.1007/s00520-017-3627-6
Harris DJ (2006) Cancer treatment-induced mucositis pain: strategies for assessment and management. Ther Clin Risk Mana 2(3):251–258
Panwar A, Rieke K, Burke WJ, Sayles H, Lydiatt WM, Prevention of Depression in Patients Being Treated for Head and Neck Cancer Trial (PROTECT) study group (2018) Identification of baseline characteristics associated with development of depression among patients with head and neck cancer: a secondary analysis of a randomized clinical trial. JAMA Otolaryngol Head Neck Surg 144(11):1004–1010. https://doi.org/10.1001/jamaoto.2018.2228
Greco MT, Roberto A, Corli O et al (2014) Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Clin Oncol 32:4149e4154. https://doi.org/10.1200/JCO.2014.56.0383
Devlin SM, Murphy JD, Yeung HN (2018) A retrospective analysis of pain burden in hospitalized young adult cancer patients compared with their older adult counterpart. J Palliat Med. https://doi.org/10.1089/jpm.2018.0212
Giuliani M, Milne R, Mc Question M (2017) Partner’s survivorship care needs: an analysis in head and neck cancer patients. Oral Oncol 71:113–121. https://doi.org/10.1016/j.oraloncology.2017.06.011
Pico JP, Avila-Garavito A, Naccache P (1998) Mucositis: its occurrence, consequences, and treatment in the oncology setting. Oncologist. 3(6):446–451
Cavalcanti AL, Macêdo DJ, Dantas FSB et al (2018) Evaluation of oral mucositis occurrence in oncologic patients under antineoplastic therapy submitted to the low-level laser coadjuvant therapy. J Clin Med 7(5):90. https://doi.org/10.3390/jcm7050090
Santos-Silva AR, Ribeiro APC, Soubhia AMP et al (2011) High incidences of DNA ploidy abnormalities in tongue squamous cell carcinoma of young patients: an international collaborative study. Oral Oncol 58(7):1127–1135. https://doi.org/10.1111/j.1365-2559.2011.03863.x
Galvis MM, Santos-Silva AR, Jardim JF et al (2017) Different patterns of expression of cell cycle control and localinvasion-related proteins in oral squamous cell affecting young patients. J Oral Pathol Med 47(1):32–39. https://doi.org/10.1111/jop.12601
Costa SFS, Brennan PA, Gomez RC et al (2017) Molecular basis of oral squamous cell carcinoma in young patients: is it any different from older patients? J Oral Pathol Med 47(6):541–546. https://doi.org/10.1111/jop.12642
Toner M, O'Regan EM (2009) Head and neck squamous cell carcinoma in the young: a spectrum or a distinct group? Part 1. Head Neck Pathol 3(3):246–248. https://doi.org/10.1007/s12105-009-0135-0
El-Mofty SK, Lu DW (2003) Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 27(11):1463–1470. https://doi.org/10.1097/00000478-200311000-00010
Toner M, O'Regan EM (2009) Head and neck squamous cell carcinoma in the young: a spectrum or a distinct group? Part 2. Head Neck Pathol 3(3):249–251. https://doi.org/10.1007/s12105-009-0137-y
O’Regan EM, Toner ME, Smyth PC, Finn SP, Timon C, Cahill S et al (2006) Distinct array comparative genomic hybridization profiles in oral squamous cell carcinoma occurring in young patients. Head Neck 28(4):330–338. https://doi.org/10.1002/hed.20354
Funding
The authors received financial support of the São Paulo Research Foundation (FAPESP) (process numbers 2018/02233-6; 2016/22862-2; 2013/18402-8; and 2012/06138-1) as well as the National Council for Scientific and Technological Development (CNPq), Brazil. The authors also state that this study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brasil (CAPES), Finance Code 001.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Morais-Faria, K., Palmier, N.R., de Lima Correia, J. et al. Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus. Support Care Cancer 28, 4345–4352 (2020). https://doi.org/10.1007/s00520-019-05241-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-019-05241-x